The following invention is directed to pharmaceutical compounds and compositions of the Formula I
useful for treating conditions mediated by α
v
β
3
and/or α
v
β
5
integrin.
下面的发明是针对化合物和组合物的公式I,用于治疗由αvβ3和/或αvβ5整合素介导的疾病。
NOWICKI R.; FABRYCY A., ROCZ. CHEM. <ROCH-AC>, 1975, 49, NO 6, 1089-1095